Safety, Tolerability and Efficacy Study of the Monoclonal Antibody, CT-011, in Patients With Metastatic Melanoma
Clinical trial NCT01435369 · COMPLETED
Trial details
- NCT number
- NCT01435369
- Sponsor
- Medivation, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2013-08-01
- Enrollment
- 103
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.